Skip to main content
Contact Us
Subscribe
E-Edition
74°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Purple Biotech Ltd. - American Depositary Shares
(NQ:
PPBT
)
2.685
UNCHANGED
Streaming Delayed Price
Updated: 3:46 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Purple Biotech Ltd. - American Depositary Shares
< Previous
1
2
3
4
Next >
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
June 01, 2024
From
Purple Biotech Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
May 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
May 23, 2024
Via
Benzinga
Purple Biotech: Q3 Earnings Insights
November 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 23, 2024
Via
Benzinga
PPBT Stock Earnings: Purple Biotech Beats EPS for Q1 2024
May 21, 2024
PPBT stock results show that Purple Biotech beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
May 10, 2024
Via
Benzinga
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
April 25, 2024
From
Purple Biotech Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
April 22, 2024
Via
Benzinga
Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024
March 28, 2024
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
March 14, 2024
From
Purple Biotech Ltd.
Via
GlobeNewswire
PPBT Stock Earnings: Purple Biotech Meets EPS for Q4 2023
March 05, 2024
PPBT stock results show that Purple Biotech met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024
February 27, 2024
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial
February 13, 2024
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Reaches Recommended Phase 2 Dose for NT219
February 01, 2024
From
Purple Biotech Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 10, 2024
Via
Benzinga
Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors
December 20, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial
December 14, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 11, 2023
Via
Benzinga
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
December 11, 2023
Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 11, 2023
It's time to start the trading week with a look at the biggest pre-market stock movers worth watching for Monday morning!
Via
InvestorPlace
Purple Biotech Fortifies NT219 Patent Protection
November 02, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Announces Closing of $5 Million Registered Direct Offering
October 19, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 17, 2023
Via
Benzinga
Purple Biotech Announces $5 Million Registered Direct Offering
October 17, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 13, 2023
Via
Benzinga
Purple Biotech Reports Potential Biomarker Data Support CM24’s Mechanism of Action
October 06, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Reports Positive Interim and Preliminary Results from NT219 Phase 1/2 Study in R/M Head & Neck Cancer
October 03, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech to Present New CM24 Pancreatic Cancer Biomarker Data at AACR Special Conference on September 28, 2023
September 21, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
Purple Biotech Reports Second Quarter 2023 Financial Results
August 22, 2023
From
Purple Biotech Ltd.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
